Increased Hematopoietic Cells in the mertk−/− Mouse Peritoneal Cavity: A Result of Augmented Migration
暂无分享,去创建一个
B. Vilen | H. Earp | G. Matsushima | Julie C. Williams | N. Wagner | H. S. Earp | Julie C. Williams | Nikki J. Wagner | Glenn K. Matsushima
[1] U. Panzer,et al. CXCR3 Mediates Renal Th1 and Th17 Immune Response in Murine Lupus Nephritis1 , 2009, The Journal of Immunology.
[2] R. Tisch,et al. The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFF , 2009, Autoimmunity.
[3] R. Eisenberg,et al. The Mer Receptor Tyrosine Kinase Is Required for the Loss of B Cell Tolerance in the Chronic Graft-versus-Host Disease Model of Systemic Lupus Erythematosus1 , 2008, The Journal of Immunology.
[4] E. Shacter,et al. Auto-Oxidation and Oligomerization of Protein S on the Apoptotic Cell Surface Is Required for Mer Tyrosine Kinase-Mediated Phagocytosis of Apoptotic Cells , 2008, The Journal of Immunology.
[5] R. Tisch,et al. MerTK is required for apoptotic cell–induced T cell tolerance , 2008, The Journal of experimental medicine.
[6] Yutaka Takahashi,et al. CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity. , 2007, Biochemical and biophysical research communications.
[7] G. Lemke,et al. TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response , 2007, Cell.
[8] G. Lemke,et al. Macrophages and Dendritic Cells Use Different Axl/Mertk/Tyro3 Receptors in Clearance of Apoptotic Cells1 , 2007, The Journal of Immunology.
[9] R. Tisch,et al. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. , 2007, Blood.
[10] Qingxian Lu,et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases , 2006, Nature Immunology.
[11] H. Snodgrass,et al. Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia , 2006, Clinical Cancer Research.
[12] D. Schatz,et al. Origins of peripheral B cells in IL-7 receptor-deficient mice. , 2006, Molecular immunology.
[13] K. Matsushima,et al. Migration of Dendritic Cells , 2005, International journal of hematology.
[14] T. Bieber,et al. Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus , 2005, The Journal of pathology.
[15] R. Birge,et al. A role for Mer tyrosine kinase in αvβ5 integrin-mediated phagocytosis of apoptotic cells , 2005, Journal of Cell Science.
[16] L. Morel,et al. Mechanisms of Peritoneal B-1a Cells Accumulation Induced by Murine Lupus Susceptibility Locus Sle21 , 2004, The Journal of Immunology.
[17] T. Rothstein,et al. Peritoneal and splenic B‐1 cells are separable by phenotypic, functional, and transcriptomic characteristics , 2004, European journal of immunology.
[18] M. G. Krukemeyer,et al. Description of B Lymphocytes and Plasma Cells, Complement, and Chemokines/Receptors in Acute Liver Allograft Rejection , 2004, Transplantation.
[19] Taku Sato,et al. Defective B1 Cell Homing to the Peritoneal Cavity and Preferential Recruitment of B1 Cells in the Target Organs in a Murine Model for Systemic Lupus Erythematosus1 , 2004, The Journal of Immunology.
[20] Hongsheng Wang,et al. Impaired Clearance of Apoptotic Cells Induces the Activation of Autoreactive Anti-Sm Marginal Zone and B-1 B Cells 1 , 2004, The Journal of Immunology.
[21] E. Wherry,et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.
[22] P. Stein,et al. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity , 2003, European journal of immunology.
[23] Jason G. Cyster,et al. Overlapping Roles of CXCL13, Interleukin 7 Receptor α, and CCR7 Ligands in Lymph Node Development , 2003, The Journal of experimental medicine.
[24] J. Charles Jennette,et al. Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase , 2002, The Journal of experimental medicine.
[25] A. Cumano,et al. Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7−/− Mice , 2001, The Journal of experimental medicine.
[26] Qingxian Lu,et al. Homeostatic Regulation of the Immune System by Receptor Tyrosine Kinases of the Tyro 3 Family , 2001, Science.
[27] R. Scott,et al. Phagocytosis and clearance of apoptotic cells is mediated by MER , 2001, Nature.
[28] J. Tellado,et al. Defense mechanisms of the peritoneal cavity , 2001, Current opinion in critical care.
[29] Don Foster,et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.
[30] D. Lacey,et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Tschopp,et al. Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.
[32] L. Rönnblom,et al. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. , 1999, Journal of immunology.
[33] P. Kenny,et al. Inflammatory processes in a murine model of intra‐abdominal abscess formation , 1999, Journal of leukocyte biology.
[34] B. Koller,et al. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. , 1999, Journal of immunology.
[35] L. Rönnblom,et al. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon‐alpha (IFN‐α) production acting on leucocytes resembling immature dendritic cells , 1999, Clinical and experimental immunology.
[36] H. Hanafusa,et al. Identification of the Product of Growth Arrest-specific Gene 6 as a Common Ligand for Axl, Sky, and Mer Receptor Tyrosine Kinases* , 1996, The Journal of Biological Chemistry.
[37] H. Snodgrass,et al. Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. , 1995, Oncogene.
[38] T. Honjo,et al. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. , 1995, International immunology.
[39] Pamela F. Jones,et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.
[40] R. Hardy,et al. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice , 1983, The Journal of experimental medicine.
[41] Robin R. Craven,et al. TAM receptors are dispensable in the phagocytosis and killing of bacteria. , 2009, Cellular immunology.
[42] M. Zouali,et al. B-lymphocytes, innate immunity, and autoimmunity. , 2005, Clinical immunology.
[43] R. Birge,et al. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. , 2005, Journal of cell science.
[44] J. Cyster,et al. Overlapping Roles of CXCL13, Interleukin 7 Receptor (cid:2) , and CCR7 Ligands in Lymph Node Development , 2003 .
[45] R. Berland,et al. Origins and functions of B-1 cells with notes on the role of CD5. , 2002, Annual review of immunology.
[46] J. Cyster,et al. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. , 2002, Immunity.
[47] H. Snodgrass,et al. Cloning and Mrna Expression Analysis of a Novel Human Protooncogene, C-merr , 2022 .